For: | Turshudzhyan A, Samuel S, Tawfik A, Tadros M. Rebuilding trust in proton pump inhibitor therapy. World J Gastroenterol 2022; 28(24): 2667-2679 [PMID: 35979162 DOI: 10.3748/wjg.v28.i24.2667] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v28/i24/2667.htm |
Number | Citing Articles |
1 |
Colby S. Sharlin, Vincent A. Mukkada, Philip E. Putnam, Scott M. Bolton. Treatment of Pediatric Eosinophilic Esophagitis: Traditional and Novel Therapies. Current Gastroenterology Reports 2023; 25(11): 289 doi: 10.1007/s11894-023-00893-6
|
2 |
Priyata Dutta, Prince Shah-Riar, Sumaita Sadida Bushra, Sharar Naiarin Haque, Zahin Islam Rafa, Fadi Hawa, Swarna Chakrabarty, Supti Dev Nath, Humayra Afrin, Nishat Shama, Farzana Khair, Sadia Maisha, Progga Kapuria, Barna Dam. Recent Trends in the Management of Eosinophilic Esophagitis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.43221
|
3 |
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, Alessandro Ottaiano, Roberto Langella, Andrea Zovi. Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence. Indian Journal of Gastroenterology 2024; 43(3): 645 doi: 10.1007/s12664-023-01501-1
|
4 |
Silvia Aura Costin, Claudiu Elisei Tanase, Alexia Anastasia Balta, Raisa-Eloise Barbu, Diana-Andreea Ciortea, Anca Stefanopol, Andreea Mechi Hagi, Anamaria Madalina Filip. Choosing the Therapeutic Strategy in Gastroesophageal Reflux Disease in Pediatric Patients: Is it a Challenge for Clinicians?. ARS Medica Tomitana 2023; 29(4): 213 doi: 10.2478/arsm-2023-0031
|
5 |
Somtochukwu Onwuzo, Antoine Boustany, Hadi Khaled Abou Zeid, Asif Hitawala, Ashraf Almomani, Chidera Onwuzo, Favour Lawrence, Jessy Mascarenhas Monteiro, Chidera Ndubueze, Imad Asaad. Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study. Cureus 2023; doi: 10.7759/cureus.34088
|
6 |
Yun-Ran Guo, Xin-Ming Liu, Gui-Xia Wang. Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis. World Journal of Diabetes 2023; 14(2): 120-129 doi: 10.4239/wjd.v14.i2.120
|
7 |
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World Journal of Cardiology 2023; 15(8): 375-394 doi: 10.4330/wjc.v15.i8.375
Abstract(491) |
Core Tip(346) |
Full Article(HTML)(6145)
|
Full Article with Cover (PDF)-1012K(143)
|
Full Article (Word)-171K(24)
|
Audio-1310K(4)
|
Peer-Review Report-333K(43)
|
Answering Reviewers-122K(45)
|
Full Article (PDF)-561K(773)
|
Full Article (XML)-403K(65)
|
Times Cited (3)
|
Total Visits (9539)
|
Open
|
8 |
Yunjing He, Jingrui Zheng, Binbin Ye, Yongzhao Dai, Ke Nie. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management. Biochemical Pharmacology 2023; 216: 115787 doi: 10.1016/j.bcp.2023.115787
|
9 |
Johanna C Meyer, Sean MacBride-Stewart , Joseph O Fadare, Ammar Abdulrahman Jairoun, Mainul Haque, Amos Massele, Santosh Kumar, Israel Abebrese Sefah, Phumzile P Skosana , Brian Godman. Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications. Cureus 2022; doi: 10.7759/cureus.31918
|